Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 139,682 | 238,183 | 134,776 | 146,630 | 185,323 |
| Marketable Securities | 262,428 | 218,957 | 234,179 | 182,509 | 0 |
| Receivables | 6,048 | 418 | 30 | 679 | 88 |
| TOTAL | $419,087 | $463,844 | $374,776 | $332,199 | $187,183 |
| Non-Current Assets | |||||
| PPE Net | 14,020 | 10,887 | 40,232 | 39,442 | 40,378 |
| Investments And Advances | 109,664 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 29,831 | 34,154 | 5,378 | 1,619 | 1,621 |
| TOTAL | $153,515 | $45,041 | $45,610 | $41,061 | $41,999 |
| Total Assets | $572,602 | $508,885 | $420,386 | $373,260 | $229,182 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,408 | 5,843 | 5,327 | 4,020 | 4,640 |
| Accrued Expenses | 24,046 | 22,120 | 12,813 | 11,049 | 17,439 |
| Other current liabilities | N/A | 2,682 | 2,048 | 900 | 748 |
| TOTAL | $58,208 | $59,963 | $35,900 | $36,707 | $33,083 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 20,943 | 23,514 | 15,712 | 13,238 | 256 |
| Other Non-Current Liabilities | 46,824 | 23,278 | 293 | 317 | 396 |
| TOTAL | $120,808 | $186,485 | $148,324 | $128,473 | $61,492 |
| Total Liabilities | $179,016 | $246,448 | $184,224 | $165,180 | $94,575 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,363 | 54,875 | 49,092 | 46,885 | 36,680 |
| Common Shares | 6 | 5 | 5 | 4 | 4 |
| Retained earnings | -665,197 | -549,221 | -416,278 | -305,850 | -185,526 |
| Other shareholders' equity | -46 | 107 | -29 | -76 | 0 |
| TOTAL | $393,586 | $262,437 | $236,162 | $208,080 | $134,607 |
| Total Liabilities And Equity | $572,602 | $508,885 | $420,386 | $373,260 | $229,182 |